Palo Alto – November 2, 2016 – Cooley advised Helix on its strategic investment from Kleiner Perkins Caufield & Byers. Helix is a personal genomics company with a simple but powerful mission: to empower every person to improve their life through DNA.
“The genomics industry is no longer just about clinical precautions and general health. It’s quickly touching all areas of our lives, from family planning to nutrition to ancestry,” said Robin Thurston, CEO of Helix. “We’re building a powerful platform for DNA discovery that enables anyone to connect with relevant, personalized applications from well-known consumer brands, trusted healthcare providers, innovative developers and everything in between.”
In addition to its investment, Helix concurrently announced new partnerships with National Geographic, Mount Sinai and Exploragen.
Under the partnerships, Helix will help bring DNA-powered insights to everyday products and experiences. National Geographic’s popular ancestry product, Geno 2.0 Next Generation, will launch on the Helix platform this November. The first Mount Sinai application on the Helix platform, available with approval of a clinician, will allow prospective parents to learn about their risks of passing on certain of the many potential inheritable genetic disorders to their children. And Exploragen is building a variety of applications on the Helix platform that harness DNA and the science of taste to match personalized epicurean experiences and products with consumers.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.